Skip to main content
Official Website of Stem Cell Mexico – Since 2002
Stem Cell Therapy Mexico

Will Stem Cell Therapy cure me?

In most cases, stem cell therapy will not cure a chronic condition, and any clinic that promises a cure should be viewed with caution.

Free Consultation

What regenerative treatment can do is reduce inflammation, support the body's repair processes and improve symptoms and function, which for many patients means less pain, better mobility, more energy or slower worsening of their condition. At Stem Cell Mexico, treatment uses only allogeneic mesenchymal stem cells (MSCs) from Wharton's jelly of the umbilical cord, applied locally or by intravenous (IV) infusion according to your condition, as a complement to your medical care. The evidence is strongest in knee osteoarthritis and degenerative disc disease, where randomized trials show greater pain relief than control treatments, and large safety analyses show a favorable safety profile. Results vary from patient to patient, and the best way to judge success is with clear goals measured before and after treatment.

This guide explains why "cure" is rarely the right expectation, what realistic success looks like for different conditions and how to decide whether treatment is worth it for you.

Why most chronic conditions are managed rather than cured

Many of the conditions people bring to us share a common pattern: damage that has built up over years, combined with ongoing processes such as chronic inflammation, wear or immune activity.

  • Osteoarthritis: cartilage that has been lost does not fully regrow.
  • Degenerative disc disease: discs lose water and height with age.
  • Neurological conditions: neurons and connections lost after stroke, brain or spinal cord injury, or in Parkinson's disease, are not fully replaced.
  • Heart failure and kidney disease: scarred tissue does not return to normal.
  • Autoimmune conditions: the immune process continues over time.

For these conditions, even the most effective medical treatments manage symptoms, slow progression or improve function rather than cure. Regenerative treatment fits the same model: it aims to improve how the body works, not to reset it to its original state.

There are exceptions in medicine, such as treating an infection or removing an early tumor, but for long-standing degenerative, neurological and metabolic conditions, management is the standard. Thinking in terms of improvement rather than cure is not a lower expectation; it is the same way the best medical care for these conditions is measured.

What realistic success looks like

ConditionRealistic goals
Knee or joint osteoarthritisLess pain, better function, postponing surgery
Degenerative disc diseaseLess back or neck pain, more comfortable sitting and sleeping
Sports and tendon injuriesLess pain, support for healing, return to activity with rehabilitation
Stroke, brain or spinal cord injuryGains in specific functions, such as balance, hand use or sensation
Parkinson's disease, multiple sclerosisSupport for energy, stiffness, mobility and well-being
Heart failure, kidney diseaseSupport for function and quality of life, measured with tests
Healthy aging, fatigueMore energy and better recovery

Some patients experience meaningful improvement, others modest change and some little difference. A clear goal turns a vague hope into something you can measure.

What the evidence shows

  • Knee osteoarthritis: a 2024 meta-analysis of randomized controlled trials in the Journal of Orthopaedic Translation found that MSC injections reduced pain more than hyaluronic acid at 12 months and improved function.
  • Degenerative disc disease: a 2026 meta-analysis of randomized trials in the Asian Spine Journal found greater pain reduction with intradiscal MSCs than with control treatments.
  • Safety: a 2026 meta-analysis of IV umbilical-cord-derived MSCs in Stem Cells Translational Medicine found temporary fever as the most consistent side effect, without an increase in serious infection, thrombosis, cancer or death in controlled trials.

Why clinics should never promise a cure

The U.S. Food and Drug Administration (FDA) has warned patients about clinics that market stem cell products as cures for many diseases, and the International Society for Stem Cell Research (ISSCR) advises patients to be cautious with promises of cures, testimonials presented as proof and claims that a treatment works for almost any condition. A responsible clinic explains what is realistic, uses a documented cell product, monitors safety and tells you when treatment is unlikely to help.

How regenerative treatment works

MSCs from Wharton's jelly act through paracrine signaling: they release anti-inflammatory, immune-modulating and trophic factors that may calm inflammation, support the repair activity of your own cells, promote small blood vessel formation and protect cells from further injury. This is why benefits are usually gradual, appearing over weeks to months as tissues respond.

What influences your result

  • The condition and its stage: earlier stages offer more opportunity, because more healthy tissue remains to support.
  • The right protocol: cell dose, route and image guidance matched to the problem.
  • Rehabilitation and lifestyle: exercise, weight, sleep, nutrition and not smoking.
  • Control of other conditions: blood sugar, blood pressure and cholesterol.
  • Continuing standard care: medications and specialist follow-up stay in place, and your doctors can help track your progress.

Safety

No medical treatment is free of risk. The most common effects are temporary: fever, headache or fatigue after an IV infusion, and pain, swelling or stiffness for a few days after a local injection. Serious complications are uncommon, and screening, sterile technique, image guidance and monitoring are part of every protocol to keep risk as low as possible.

What our patients usually receive

Based on the treatment plans our team prepares, typical protocols at Stem Cell Mexico include:

  • For joints or the spine: 20 to 40 million Wharton's jelly MSCs per area by direct injection with ultrasound or fluoroscopy guidance, often with platelet-rich plasma (PRP).
  • For systemic and neurological goals: IV infusion, usually 100 to 200 million cells, and in selected neurological cases an additional intrathecal application.
  • One night at our facilities, the consultation with your doctor and the stem cell specialist, pre-treatment tests and ground transportation from the San Diego airport area.

Treatment plans range from about $1,800 to $9,500 USD, depending on the condition and plan. Our team stays in contact after treatment to follow your progress and decide whether a second application could help.

What happens if I do not notice improvement?

Improvement is often gradual, so the first step is patience: many changes appear over weeks to months. Our team stays in contact after treatment and reviews your progress at regular intervals. If, after a reasonable period, you notice little change, the doctor reviews your measures and discusses options, which may include a second application, adding PRP or rehabilitation, adjusting other parts of your care or considering a different treatment. Every option is discussed openly, and no further treatment is recommended unless there is a medical reason for it.

Why a second application is sometimes recommended

For some patients, especially those with advanced joint degeneration, chronic neurological conditions or systemic goals, the effect of a single application can be strengthened by a second one months later. This decision is based on how you responded the first time, your measures and the doctor's review, rather than on a fixed package.

Personal stories versus measurements

Testimonials can be encouraging, but every person and condition is different. The most reliable way to know what treatment did for you is to compare your own measures before and after, such as pain scores, walking distance, standardized neurological scales or lab results. We encourage every patient to record a baseline so that results are clear.

How to decide whether treatment is worth it for you

Ask yourself and the doctor:

  1. What is my goal? Less pain walking, better sleep, more independence, more energy.
  2. Is that goal realistic for my condition and stage?
  3. How will we measure it? Pain scores, walking distance, standardized scales or lab tests.
  4. What else will I do to support it? Exercise, rehabilitation, weight management.
  5. What are the alternatives? Including surgery or other treatments, and their timing.

If the answers point to a realistic, meaningful goal, treatment may be a good option. If not, the doctor will tell you.

Questions to ask during your evaluation

  • What can regenerative treatment realistically achieve for my condition?
  • How will we measure success, and when?
  • What will happen if I do not notice improvement?
  • How does treatment fit with my current care and medications?

Bottom line

Stem cell therapy will not cure most chronic conditions, but it can reduce inflammation, support repair and improve symptoms and function for many patients, with the strongest evidence in knee osteoarthritis and degenerative disc disease and a favorable safety profile. At Stem Cell Mexico, Wharton's jelly MSCs are used as a complement to your medical care, with clear goals and follow-up, and results vary from patient to patient. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your condition, goals and medical history.

References

  1. International Society for Stem Cell Research (ISSCR): The ISSCR Guide to Stem Cell Treatments (opens in a new tab)
  2. U.S. Food and Drug Administration (FDA): Important patient and consumer information about regenerative medicine therapies (opens in a new tab)
  3. Tabet CG et al. Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Translation, 2024 (opens in a new tab)
  4. Rahyussalim et al. Intradiscal mesenchymal stem cell therapy for degenerative disc disease: a systematic review and meta-analysis of randomized trials. Asian Spine Journal, 2026 (opens in a new tab)
  5. Hum C et al. Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis. Stem Cells Translational Medicine, 2026 (opens in a new tab)

Request your medical evaluation

A clearer path starts here.

Tell us a little about yourself. We’ll help you understand the next step.

Vania, patient coordinator at Stem Cell Mexico

Vania, our patient coordinator

Your questions. Your travel plans.
A real person to help.

Talk to Vania on WhatsApp (opens in a new tab)

What happens next?

  1. Your advisor contacts you.
  2. We explain the medical review.
  3. You explore your options.

Call +1 800 646 0290

Let’s begin with you.

Your inquiry starts a conversation. Treatment requires medical evaluation.

Vania · Patient Advisor

Start my free evaluation
Free Consultation